Check patentability & draft patents in minutes with Patsnap Eureka AI!

Preparation method of caspofungin acetate impurity G

A technology of caspofungin acetate and caspofungin, which is applied in the chemical field, can solve the problems of not preparing high-purity caspofungin acetate impurity G, etc., and achieve the effect of meeting market demand, simple steps, and high yield

Pending Publication Date: 2021-12-17
HANGZHOU ZHONGMEI HUADONG PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] No other references have specific reports on caspofungin impurity G or caspofungin acetate impurity G at present, and there is no relevant report about preparing high-purity caspofungin acetate impurity G in the prior art, therefore, need to develop A method for preparing high-purity caspofungin acetate impurity G is proposed to meet the needs of the enterprise itself and the market for the reference substance of caspofungin acetate impurity G

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of caspofungin acetate impurity G
  • Preparation method of caspofungin acetate impurity G
  • Preparation method of caspofungin acetate impurity G

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] First, determine the reducing agent, crude solvent, packing material, mobile phase, and elution gradient.

[0032] 1. Determination of reducing agent

[0033] Take 8g of neomocontin B0, 1.2g of phenylboronic acid (Phenylboronic Acid) and 200mL of tetrahydrofuran (THF) and mix and dissolve, heat and dehydrate, add BSTFA (N,O-bis(trimethylsilyl)trifluoroacetamide) 5mL, Use reducing agent to reduce again, use 5mL hydrochloric acid to quench at the end of reaction, obtain caspofungin impurity G crude product solution, the most critical in the reaction is the kind of reducing agent, several reducing agents are screened, including: borane tetrahydrofuran, dihydrofuran Methylsulfide borane, sodium borohydride, sodium acetate borohydride, the purity of the product of substrate B0 after reduction with different reducing agents is used as the investigation index, after reduction for 1h, the purity of impurity G under different reducing agents (%) The results are shown in Table 1...

Embodiment 2

[0063] According to the same method and chromatographic conditions as in Example 1, 3.5 g of crude product G with a purity of 41% was dissolved in 0.1% acetic acid aqueous solution, and finally, the content of caspofungin acetate impurity G in the gradient eluent collected was at the level of purity More than 95%, obtain the solid powder of 0.7g caspofungin acetate impurity G after freeze-drying, product yield is 50%, as image 3 As shown in the detection spectrum, the product purity is 97.85%.

Embodiment 3

[0065] According to the same method and chromatographic conditions as in Example 1, get 4g and have a purity of 41% crude product G and dissolve it in 0.1% acetic acid aqueous solution. Finally, the content of caspofungin acetate impurity G in the collected gradient eluent is at a purity of 95%. Above, obtain the solid powder of 0.85g caspofungin acetate impurity G after freeze-drying, product yield is 52%, as Figure 4 As shown in the detection spectrum, the product purity is 98.08%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a preparation method of a caspofungin acetate impurity G. The preparation method comprises the following steps of 1) taking pneumocandin B0 as a raw material, and obtaining a caspofungin acetate impurity G crude product through chemical synthesis; 2) dissolving the caspofungin impurity G crude product with a solvent to prepare a crude product solution, and filtering; 3) separating and purifying the filtered crude product solution through a chromatographic column in a preparation system, and collecting an eluent; and 4) carrying out freeze drying on the qualified eluent to obtain caspofungin acetate impurity G solid powder with the purity of 95% or above. The preparation method comprises the following steps of by taking the intermediate pneumocandin B0 of caspofungin acetate as the raw material, reducing a group at a specific position under the action of a reducing agent to directly obtain the caspofungin acetate impurity G crude product, and then by taking the impurity G crude product as a raw material, obtaining caspofungin acetate impurity G solid powder with the purity of 95% or above through the method for preparing the chromatography, and the requirements of enterprises and markets can be met; and the preparation method is simple in step, stable in condition, high in yield and suitable for large-scale production.

Description

technical field [0001] The invention belongs to the field of chemistry, and in particular relates to a preparation method of caspofungin acetate impurity G. Background technique [0002] Caspofungin acetate is the first echinocandin antifungal drug. It was first approved by the US Food and Drug Administration (FDA) on January 26, 2001. It is mainly used for the treatment of invasive candidiasis and other diseases. Ineffective or intolerable invasive aspergillosis and empirical treatment of neutropenia and suspected fungal infections in patients with fever, as a representative of a new class of echinocandin antibiotics, caspofungin acetate It has the obvious advantages of high selectivity, good antibacterial activity, high safety, and less drug resistance. [0003] Caspofungin acetate is firstly fermented by Glarea Lozoyensis to obtain the fermentation product, and then the fermented product undergoes solid-liquid separation, leaching, adsorption analysis, concentration and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/56C07K1/36C07K1/34C07K1/20
CPCC07K7/56
Inventor 陈辅辰周陈锋裴苏俐张军伟颜林江施林峰
Owner HANGZHOU ZHONGMEI HUADONG PHARMA
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More